About this term
- Quick definition
- An atypical antidepressant that affects dopamine and norepinephrine signaling. Used for depression, and separately for smoking cessation and prevention of seasonal depressive episodes.
- Full clinical definition
- Bupropion inhibits the reuptake of norepinephrine and dopamine. It does not act significantly on serotonin. It is FDA approved for major depressive disorder, prevention of seasonal major depressive episodes (sustained-release and extended-release formulations), and, under separate brand and indication, smoking cessation. Available as immediate-release, sustained-release (SR), and extended-release (XL) formulations.
- Epidemiology
- Bupropion is among the most prescribed antidepressants in the United States. It is one of the most common second-line choices when an SSRI does not produce remission, and it is a frequent augmentation choice in the STAR*D trial sequence (Trivedi et al., 2006).
- What it can feel like
- For people who respond, energy and motivation often improve before mood. Many describe a clearer head and an easier start to the day within the first three to four weeks. Some people notice early activation that feels like jitteriness or insomnia, especially if the dose is started high or taken late in the day.
- Why it is chosen
- It is often chosen when low motivation, fatigue, and anhedonia dominate, or when sexual side effects from SSRIs or SNRIs are a concern. It is also a common choice when weight gain is a concern with other antidepressants. It does not generally cause sexual side effects and is weight-neutral or weight-reducing for many patients.
- How clinicians assess response
- PHQ-9 over six to eight weeks. Sleep, appetite, energy, and motivation are tracked alongside mood. Blood pressure is checked periodically because bupropion can produce small increases in some patients.
- Common side effects
- Insomnia, dry mouth, headache, agitation, decreased appetite, and tremor. Bupropion lowers the seizure threshold and is generally avoided in people with a history of seizures, eating disorders (anorexia nervosa or bulimia), or active heavy alcohol use. Risk of seizure is dose-related and is one reason maximum doses are firm.
- Treatment implications
- Bupropion is a first-line option in current APA guidelines, alone or as an augmenting agent. It is the most common first-line choice for prevention of winter-pattern seasonal depression and is started in early fall, before symptoms typically begin.
- Related terms
- Antidepressant. SSRI. SNRI. Seasonal depression. Medication management.
- Related articles
- Treatment. Antidepressant comparison. Seasonal depression (Types).
Sources
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder.
- Trivedi MH, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D. Am J Psychiatry. 2006.
- Modell JG, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry. 2005.
